Tag Archives: James Jang

Yield10 Bioscience Inc (YTEN) Receives a Buy from Aegis Capital

In a report released today, James Jang from Aegis Capital maintained a Buy rating on Yield10 Bioscience Inc (YTEN – Research Report), with a price target of $2. The company’s shares closed last Monday at $0.98. Jang wrote: “We expect

Yield10 Bioscience Inc (YTEN) Gets a Buy Rating from Maxim Group

In a report released today, James Jang from Maxim Group maintained a Buy rating on Yield10 Bioscience Inc (YTEN – Research Report), with a price target of $4.50. The company’s shares closed yesterday at $1.05. Jang said: “Yesterday, post-close, Yield10

Maxim Group Sticks to Its Buy Rating for BioHiTech Global Inc (BHTG)

Maxim Group analyst James Jang reiterated a Buy rating on BioHiTech Global Inc (BHTG – Research Report) today and set a price target of $7. The company’s shares opened today at $2.96. Jang commented: “BioHiTech Global (BHTG) reported 4Q18 results

Navigator Holdings (NVGS) Gets a Buy Rating from Maxim Group

Maxim Group analyst James Jang reiterated a Buy rating on Navigator Holdings (NVGS – Research Report) today and set a price target of $16. The company’s shares closed yesterday at $11.19. Jang said: “Navigator Holdings (NVGS) reported 4Q18 results below

Maxim Group Reiterates a Buy Rating on Tecogen (TGEN)

Maxim Group analyst James Jang reiterated a Buy rating on Tecogen (TGEN – Research Report) today and set a price target of $5. The company’s shares opened today at $3.81. Jang noted: “Tecogen (TGEN) reported 4Q18 results which were mixed

Maxim Group Reaffirms Their Buy Rating on StealthGas (GASS)

In a report released today, James Jang from Maxim Group maintained a Buy rating on StealthGas (GASS – Research Report), with a price target of $5.50. The company’s shares opened today at $3.51. Jang noted: “We hosted investor meetings with